PrintBio is deploying technologies utilized to manufacture and implant the first 3D-bioprinted living tissues in patients.
PrintBio is the only clinical-stage regenerative medicine company solving medical challenges with custom-engineered 3D-bioprinted living implants. Leveraging first in human clinical experience, PrintBio is developing an array of products, beginning with 3DMatrix™, a 3D-printed monofilament bioresorbable surgical mesh (pending 510(k) FDA approval), utilizing its proprietary technologies clinically tested in patients.
Profile Description
PrintBio is deploying technologies utilized to manufacture and implant the first 3D-bioprinted living tissues in patients.
